CIK 0001513525 · Non-accelerated filer<br>Smaller reporting company
Azora Therapeutics, Inc. (DE)
Sign in to watch- Ticker
- AZR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800667150
- Phone
- 434-422-9800
- Business address
- 16501 VENTURA BLVD, SUITE 400, ENCINO, CA, 91436
- Former names
- ADIAL PHARMACEUTICALS, INC., Adial Pharmaceuticals, L.L.C., ADial Pharmaceuticals, L.L.C.
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market buy Director bought 25,000 shares at an average $2.69 ($67,300)
- 4 Gift Director gave 312,990 shares (gift)
- 8-K Event Unregistered share sale · Other events
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Executive or director change · Other events
- 4 Derivatives Options or other derivatives
- S-3 Offering Registration Statement
- 4 Open-market buy Chief Executive Officer bought 20,600 shares at an average $2.67 ($55,071)
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market buy Director bought 10,000 shares at $2.85 ($28,500)
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Unregistered share sale · Other events
- 8-K Event Executive or director change · Other events
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 16 of 30 · 581 filings